Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

Interest Coverage 36.29
BRLI's Interest Coverage is ranked lower than
56% of the 141 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 80.71 vs. BRLI: 36.29 )
Ranked among companies with meaningful Interest Coverage only.
BRLI' s Interest Coverage Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 36.29
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

» BRLI's 10-Y Financials

Financials (Next Earnings Date: 0)

Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2014

BRLI Guru Trades in Q4 2014

Joel Greenblatt 11,951 sh (New)
Steven Cohen 46,800 sh (New)
Paul Tudor Jones 28,610 sh (+31.84%)
Mario Gabelli 59,000 sh (+1.72%)
Chase Coleman 720,000 sh (unchged)
John Hussman 59,000 sh (unchged)
Chuck Royce 206,300 sh (-26.56%)
» More
Q1 2015

BRLI Guru Trades in Q1 2015

John Hussman 203,000 sh (+244.07%)
Chuck Royce 289,100 sh (+40.14%)
Joel Greenblatt 13,925 sh (+16.52%)
Mario Gabelli 65,000 sh (+10.17%)
Chase Coleman Sold Out
Steven Cohen Sold Out
Paul Tudor Jones 21,100 sh (-26.25%)
» More
Q2 2015

BRLI Guru Trades in Q2 2015

Jim Simons 57,804 sh (New)
John Hussman 203,000 sh (unchged)
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 62,600 sh (-3.69%)
Chuck Royce 201,200 sh (-30.40%)
» More
Q3 2015

BRLI Guru Trades in Q3 2015

Jim Simons Sold Out
Chuck Royce Sold Out
John Hussman Sold Out
Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with BRLI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research
Traded in other countries:BFR.Germany,

Bio-Reference Laboratories Inc is a New Jersey corporation incorporated on December 24, 1981. It offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. It also offers laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The Company is engaged in esoteric testing, molecular diagnostics, anatomical pathology, genetics, womens health and correctional health care. The Company has a network of approximately 116 patient service centers located in the Northeast (in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in New Jersey, Maryland, Pennsylvania, Delaware and Connecticut. It offers laboratory services to physician offices in these areas with an infrastructure that includes a comprehensive logistical department, phlebotomy services and phlebotomy draw stations. The Company operates a clinical knowledge management service through its PSIMedica business unit. The system uses customer data from laboratory results, pharmaceutical data, claims data and other data sources provide administrative and clinical decision support systems that enable customers to provide quality and efficient healthcare to their populations. It also operates a web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. The Company competes with three types of providers in a highly fragmented and competitive industry: hospital laboratories, physician-office laboratories and other independent clinical laboratories. Its competitors in the New York metropolitan area are Quest Diagnostics (DGX) and Laboratory Corporation of America (LH). The Company is subject to federal and state laws and regulations regarding the protection of the environment, the health and safety of employees, and the handling, transportation and disposal of medical specimens, and infectious and hazardous wastes.



Buy Back


Valuation & Return


More Statistics

Revenue (TTM) (Mil) $882.5
EPS (TTM) $ 1.83
Short Percentage of Float15.74%
52-Week Range $26.32 - 47.49
Shares Outstanding (Mil)27.80

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)